OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Johnson and Johnson/  US4781601046  /

NYSE
31/05/2024  22:10:00 Chg. +1.39 Volume Bid13:01:50 Ask13:01:50 Market Capitalization Dividend Y. P/E Ratio
146.67USD +0.96% 14.62 mill.
Turnover: 1.62 bill.		 146.67Bid Size: 200 148.00Ask Size: 500 352.99 bill.USD 3.20% 10.57
GlobeNewswire 28/05 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 01/05 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 17/04 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 10/04 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 05/04 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 26/03 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 15/03 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 06/03 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 24/01 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 23/01 J&J to pay $700M in talc powder probe settlement
TeleTrader 23/01 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 23/01 Johnson & Johnson Q4 earnings preview
TeleTrader 22/01 Earnings preview: Tesla takes center stage
TeleTrader 08/01 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 04/12/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 07/11/2023 J&J to begin trials with surgical robot
TeleTrader 17/10/2023 J&J's Q3 sales up 6.8% to $21.4 billion
TeleTrader 03/10/2023 J&J's $223.8M talc powder case fine overturned
TeleTrader 29/08/2023 US gov't reveals drugs subject to Medicare price debate
TeleTrader 20/07/2023 J&J highest since January as Q2 results top estimates
TeleTrader 20/07/2023 J&J's Q2 sales rise by 6.3% to $25.5 billion
TeleTrader 18/07/2023 J&J joins drug price suits against US gov't
TeleTrader 04/05/2023 J&J's Kenvue reportedly valued at $41B for IPO